- Home
- MREO vs BCHT Comparison
MREO vs BCHT Comparison
Compare MREO & BCHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | BCHT |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | 15 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 61.7M |
| IPO Year | 2017 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MREO | BCHT |
|---|---|---|
| Price | $0.35 | $2.11 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $3.13 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 1.5M | 107.6K |
| Earning Date | 03-19-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | N/A | $7.24 |
| Revenue Next Year | $6,363.05 | $7.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $2.10 |
| 52 Week High | $2.94 | $2.45 |
Technical Indicators
Market Signals| Indicator | MREO | BCHT |
|---|---|---|
| Relative Strength Index (RSI) | 34.82 | 37.24 |
| Support Level | $0.20 | $2.13 |
| Resistance Level | $0.42 | $2.39 |
| Average True Range (ATR) | 0.03 | 0.14 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 22.62 | 15.15 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About BCHT Birchtech Corp. Common Stock
Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.